Company Data
Forte Biosciences Inc.
Ticker
FBRX
Current Price
$13.55 128.69%
Market Cap
$19.8M
Price Target
Refer to Report
Volume
29.5M
52wk Range
$4.11 - $21.25
Overview
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.